Cargando…
Current Challenges Towards the Development of a Blood Test for Parkinson’s Disease
Parkinson’ disease (PD) is the second most prevalent neurodegenerative disease worldwide. To date, there is no disease-modifying agent, and current medical treatment only provides symptomatic benefits. Early diagnosis of PD would be useful in clinical practice to identify patients for clinical trial...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665557/ https://www.ncbi.nlm.nih.gov/pubmed/26852683 http://dx.doi.org/10.3390/diagnostics4040153 |